Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2021-11-03 2021-11-02
Drug Identification Number 02486989 02486989
Brand name CASPOFUNGIN FOR INJECTION CASPOFUNGIN FOR INJECTION
Common or Proper name Caspofungin for Injection 50 mg Vial 10 mL Caspofungin for Injection 50 mg Vial 10 mL
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients CASPOFUNGIN CASPOFUNGIN
Strength(s) 50MG 50MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 mL 10 mL
ATC code J02AX J02AX
ATC description ANTIMYCOTICS FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-14 2021-07-14
Estimated end date 2021-11-02 2021-11-02
Actual end date 2021-11-02 2021-11-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments